AB&B BIO-TECH-B (02627) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend

Bulletin Express03-19 17:22

Ab&B Bio-Tech CO., LTD. JS (stock code: 02627, “AB&B BIO-TECH-B”) announced that its Board of Directors will convene on 31 March 2026. The agenda includes:

1. Review and approval of the audited consolidated financial results for the year ended 31 December 2025. 2. Consideration of a recommendation for a final dividend, if any. 3. Discussion of other customary matters.

The meeting will be chaired by Executive Director and Board Chairman Mr. An Youcai. The Board currently comprises nine members: three executive directors (Mr. An Youcai, Ms. Li Runxiang, Mr. He Yiming), three non-executive directors (Mr. Cheng Qianwen, Mr. Yu Jianlin, Mr. Du Mu) and three independent non-executive directors (Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei).

The company intends to release its FY2025 audited results and any proposed final dividend following Board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144477582?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144477582","market":"us","top_or_hot":-1,"title":"AB&B BIO-TECH-B (02627) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Ab&B Bio-Tech CO., LTD. JS (stock code: 02627, “AB&B BIO-TECH-B”) announced that its Board of Directors will convene on 31 March 2026. The agenda includes:</p>\n<p>1. Review and approval of the audited consolidated financial results for the year ended 31 December 2025.\n2. Consideration of a recommendation for a final dividend, if any.\n3. Discussion of other customary matters.</p>\n<p>The meeting will be chaired by Executive Director and Board Chairman Mr. An Youcai. The Board currently comprises nine members: three executive directors (Mr. An Youcai, Ms. Li Runxiang, Mr. He Yiming), three non-executive directors (Mr. Cheng Qianwen, Mr. Yu Jianlin, Mr. Du Mu) and three independent non-executive directors (Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei).</p>\n<p>The company intends to release its FY2025 audited results and any proposed final dividend following Board approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AB&B BIO-TECH-B (02627) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAB&B BIO-TECH-B (02627) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-19 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ab&B Bio-Tech CO., LTD. JS (stock code: 02627, “AB&B BIO-TECH-B”) announced that its Board of Directors will convene on 31 March 2026. The agenda includes:</p>\n<p>1. Review and approval of the audited consolidated financial results for the year ended 31 December 2025.\n2. Consideration of a recommendation for a final dividend, if any.\n3. Discussion of other customary matters.</p>\n<p>The meeting will be chaired by Executive Director and Board Chairman Mr. An Youcai. The Board currently comprises nine members: three executive directors (Mr. An Youcai, Ms. Li Runxiang, Mr. He Yiming), three non-executive directors (Mr. Cheng Qianwen, Mr. Yu Jianlin, Mr. Du Mu) and three independent non-executive directors (Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei).</p>\n<p>The company intends to release its FY2025 audited results and any proposed final dividend following Board approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02627","symbol_name":"中慧生物-B","start_time":0,"source_url":"","article_id":"1144477582","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144477582","pubTimestamp":1773912143,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Ab&B Bio-Tech CO., LTD. JS (stock code: 02627, “AB&B BIO-TECH-B”) announced that its Board of Directors will convene on 31 March 2026. The agenda includes: 1. Review and approval of the audited...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02627":"中慧生物-B"},"translate_title":"AB&B BIO-TECH-B(02627)安排2026年3月31日董事会会议批准2025财年经审核业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02627":1},"content_text":"Ab&B Bio-Tech CO., LTD. JS (stock code: 02627, “AB&B BIO-TECH-B”) announced that its Board of Directors will convene on 31 March 2026. The agenda includes:\n1. Review and approval of the audited consolidated financial results for the year ended 31 December 2025.\n2. Consideration of a recommendation for a final dividend, if any.\n3. Discussion of other customary matters.\nThe meeting will be chaired by Executive Director and Board Chairman Mr. An Youcai. The Board currently comprises nine members: three executive directors (Mr. An Youcai, Ms. Li Runxiang, Mr. He Yiming), three non-executive directors (Mr. Cheng Qianwen, Mr. Yu Jianlin, Mr. Du Mu) and three independent non-executive directors (Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei).\nThe company intends to release its FY2025 audited results and any proposed final dividend following Board approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144477582","isCrawlerRequest":true}